MedPath

A Comparison of a specific blood marker for coagulation in Covid 19 patients with and without diabetes as a comorbidities so that to assess the impact of diabetes with covid disease severity

Phase 2
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2021/10/037259
Lead Sponsor
DR TMA PAI HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ALL COVID POSITIVE PATIENTS FROM ABOVE 18 YEARS OF AGE ADMITTED IN DR TMA PAI HOSPITAL FROM 1 MARCH 2020 TO 30 SEPTEMBER 2020

Exclusion Criteria

PATIENTS WITH TYPE 1 DM

PATIENTS WITH PRE EXISTING HISTORY OF THROMBOEMBOLISM AND DIC

PATIENTS ON ANTICOAGULANTS

PREGNANT AND LACTATING WOMEN

KNOWN CASE OF CKD AND CLD

PATIENTS WITH MALIGNANCY NOT UNDER REMISSIO

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
COMPARISON OF D DIMER VALUES IN COVID PATIENTS WITH AND WITHOUT DIABETESTimepoint: 2 YEARS
Secondary Outcome Measures
NameTimeMethod
COMPARISON OF D DIMER VALUES IN COVID PATIENTS WITH UNCONTROLLED AND CONTROLLED DIABETESTimepoint: 2 YEARS
© Copyright 2025. All Rights Reserved by MedPath